Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-140-8 | CAS number: 10043-52-4
Toxicological information
Developmental toxicity / teratogenicity
Currently viewing:
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Comparable to OECD guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Calcium chloride
- EC Number:
- 233-140-8
- EC Name:
- Calcium chloride
- Cas Number:
- 10043-52-4
- Molecular formula:
- CaCl2
- IUPAC Name:
- calcium dichloride
- Details on test material:
- Test substance: Tine white granular material marked with FDA 71-87.
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- Dutch
Administration / exposure
- Route of administration:
- oral: gavage
- Duration of treatment / exposure:
- 6th to 18th day of pregnancy
- Frequency of treatment:
- daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1.69, 7.85, 35.6, 169 mg/kg/day
Basis:
- Control animals:
- other: sham-treated
- Details on study design:
- Sex: female
Duration of test: up to the last day of pregnancy
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- > 169 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- > 169 mg/kg bw/day
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 1: Fate Summary
-------------------------------------------------------
Group Material Dose*** Total Surviving at Term
---------------- ---------------
mg/kg Mated Pregnant Total Pregnant*
-------------------------------------------------------
341 Sham 0.0 18 13 18 13
342 6-AN** 2.5 20 10 19 10
347 CaCl2 1.69 22 13 18 12
348 CaCl2 7.85 22 14 16 11
349 CaCl2 35.6 17 14 14 12
350 CaCl2 169.0 16 16 14 14
--------------------------------------------------------
* Includes all dams examined at term
** Positive Control: 2.5 mg/kg of 6-aminonicotinamide
dosed on Day 9
*** Administered as a water solution
- Table 2: Reproduction Data
--------------------------------------------------------
Group 341 342 347 348 349 350
Dose (mg/kg) Sham 6-AN* 1.69 7.85 35.6 169.0
--------------------------------------------------------
-----Pregnancies-----
Total No. 13 10 13 14 14 16
Died or Aborted (before Day 29)
0 1 1 3 2 2
To term (on Day 29)13 10 12 11 12 14
-----Corpora Lutea-----
Total No. 174 122 148 129 138 146
Average/dam mated 9.67 6.42 7.40 7.17 8.63 10.4
-----Live Litters-----
Total No.** 12 10 12 9 11 12
-----Implant Sites-----
Total No. 69 56 86 63 69 72
Average/dam** 5.31 5.60 7.17 7.73 5.75 5.14
-----Resorptions-----
Total No.** 4 2 12 8 8 4
Dams with 1 or more sites resorbed
3 1 4 4 6 3
Dams with all sites resorbed
1 - - 2 1 -
Per cent partial resorptions
23.1 10.0 33.3 36.4 50.0 21.4
Per cent complete resorptions
7.69 - - 18.2 8.33 -
-----Live Fetuses-----
Total No. 65 54 74 55 61 58
Average/dam** 5.00 5.40 6.17 5.00 5.55 4.83
Sex ratio (M/F) 0.86 0.74 1.47 1.04 1.16 1.24
-----Dead Fetuses-----
Total** - - - - - 10
Dams with 1 or more dead
- - - - - 2
Dams with all dead
- - - - - 1
Per cent partial dead
- - - - - 14.3
Per cent all dead - - - - - 7.14
-----Average Fetus Weight (g)-----
38.2 33.8 37.3 38.0 36.8 39.2
---------------------------------------------------------
* Positive Control: 2.5 mg/kg of 6-aminonicotinamide dosed
on Day 9
** Includes only those dams examined at term.
- Table 3: Summary of Skeletal Findings***
---------------------------------------------------------
Group No. 341 342 347 348 349 350
Dose (mg/kg) Sham 6-AN** 1.69 7.85 35.6 169.0
---------------------------------------------------------
Live Fetuses Examined
(at term) 65/12 53/10* 74/12 54/9* 61/11 58/12
-----Sternebrae-----
Incomplete oss. - - 2/1 - 1/1 -
Scrambled
Bipartite - - 1/1 - - -
Fused - 1/1 - - - -
Extra
Missing
Other
-----Rids-----
Incomplete oss.
Fused/split - 2/1 - - - -
Wavy
Less than 12
More than 13
Other
-----Vertebrae-----
Incomplete oss.
Scrambled - 5/1 - - - -
Fused
Extra ctrs. oss.
Scoliosis - 1/1 - - - -
Tail defects - 10/3 - - - -
Other; spina bifida
-----Skull-----
Incomplete closure
1/1 - - - - -
Missing
Craniostosis - - 2/1 - - -
Other
-----Extremities-----
Incomplete oss.
Missing
Extra
-----Miscellaneous-----
---------------------------------------------------------
* One pup lost in processing
** Positive Control: 2.5 mg/kg of 6-aminonicotinamide
dosed on Day 9
*** Numerator = Number of fetuses affected
- Table 4: Summary of Soft Tissue Abnormalities
---------------------------------------------------------
Group Material Dose Level Dam Number Description
(mg/kg) of Pups
---------------------------------------------------------
342 6-AN* 2.5 Z7640 2 Medial rotation
of hind limbs
----------------------------------------------------------
* Positive Control: 2.5 mg/kg of 6-aminonicotinamide dosed
on Day 9
- Table 5: Average body Weights*** (g)
---------------------------------------------------------
Group Material Dose Day0 Day6 Day12 Day18 Day29**
Level
(mg/kg)
---------------------------------------------------------
341 Sham 0.0 2.23 2.32 2.40 2.48 2.59
(13)
342 6-AN* 2.5 1.86 1.94 2.03 2.08 2.18
(10)
347 CaCl2 1.69 2.20 2.31 2.43 2.51 2.64
(12)
348 CaCl2 7.85 2.12 2.16 2.16 2.25 2.33
(11)
349 CaCl2 35.6 2.22 2.31 2.34 2.40 2.50
(12)
350 CaCl2 169.0 2.27 2.39 2.41 2.46 2.50
(14)
---------------------------------------------------------
* Positive Control: 2.5 mg/kg of 6-aninonicotinamide dosed
on Day 9
** Number of surviving dams in parentheses (c.f. Table 1)
*** Of pregnant dams
Applicant's summary and conclusion
- Conclusions:
- The administration of up to 169 mg/kg (body weight) of the
test material to pregnant rats for 13 consecutive days had
no clearly discernible effect on nidation or on maternal or
fetal survival. The number of abnormalities seen in either
soft or skeletal tissues of the test groups did not differ
from the number occurring spontaneously in the sham-treated
controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
